No Data
No Data
Earnings Preview: DMAC to Report Financial Results Post-market on May 13
Press Release: DiaMedica Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update May 14, 2025
We're Hopeful That DiaMedica Therapeutics (NASDAQ:DMAC) Will Use Its Cash Wisely
Why Ericsson Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
H.C. Wainwright Maintains DiaMedica Therapeutics(DMAC.US) With Buy Rating, Raises Target Price to $10
Lake Street Maintains DiaMedica Therapeutics(DMAC.US) With Buy Rating, Maintains Target Price $11